Cargando…
Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012
Hepatocellular carcinoma (HCC), accounting for the majority of liver cancer, is a highly aggressive malignancy with poor prognosis and therefore adds up the financial burden. Incidence data of HCC in three decades during 1983-2012 were extracted from the Surveillance, Epidemiology, and End Results (...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312351/ https://www.ncbi.nlm.nih.gov/pubmed/27486977 http://dx.doi.org/10.18632/oncotarget.10930 |
_version_ | 1782508190147018752 |
---|---|
author | Wang, Shuncong Sun, Huanhuan Xie, Zhinan Li, Jie Hong, Guobin Li, Dan Mallampati, Saradhi Zhou, Xiuling Zhou, Cuiling Zhang, Hongyu Cheng, Zhibin Shan, Hong Ma, Haiqing |
author_facet | Wang, Shuncong Sun, Huanhuan Xie, Zhinan Li, Jie Hong, Guobin Li, Dan Mallampati, Saradhi Zhou, Xiuling Zhou, Cuiling Zhang, Hongyu Cheng, Zhibin Shan, Hong Ma, Haiqing |
author_sort | Wang, Shuncong |
collection | PubMed |
description | Hepatocellular carcinoma (HCC), accounting for the majority of liver cancer, is a highly aggressive malignancy with poor prognosis and therefore adds up the financial burden. Incidence data of HCC in three decades during 1983-2012 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database with incidence rates of 1.9, 3.1 and 4.9 per 100,000 respectively. In addition, to evaluate the survival changes in the same period, a total of 63,640 HCC cancer cases were accessed from SEER database. The six-month relative survival rates improved each decade from 31.0% to 42.9% to 57.2% and the higher increase can be seen in the last two decades. More importantly, the disparities of survival among different racial groups and socioeconomic status (SES) were confirmed by the inferiority of survival in Black race and high-poverty group respectively. This research analyzed the incidence and survival data of HCC in the past three decades and may help predict the future trends of incidence and survival. Furthermore, this study may help better design healthcare policies and clinical management programs to balance the disparities of survival between SES groups, races, ages and sexes confirmed in this study and thereby improve the clinical management of HCC. |
format | Online Article Text |
id | pubmed-5312351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53123512017-03-06 Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 Wang, Shuncong Sun, Huanhuan Xie, Zhinan Li, Jie Hong, Guobin Li, Dan Mallampati, Saradhi Zhou, Xiuling Zhou, Cuiling Zhang, Hongyu Cheng, Zhibin Shan, Hong Ma, Haiqing Oncotarget Research Paper Hepatocellular carcinoma (HCC), accounting for the majority of liver cancer, is a highly aggressive malignancy with poor prognosis and therefore adds up the financial burden. Incidence data of HCC in three decades during 1983-2012 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database with incidence rates of 1.9, 3.1 and 4.9 per 100,000 respectively. In addition, to evaluate the survival changes in the same period, a total of 63,640 HCC cancer cases were accessed from SEER database. The six-month relative survival rates improved each decade from 31.0% to 42.9% to 57.2% and the higher increase can be seen in the last two decades. More importantly, the disparities of survival among different racial groups and socioeconomic status (SES) were confirmed by the inferiority of survival in Black race and high-poverty group respectively. This research analyzed the incidence and survival data of HCC in the past three decades and may help predict the future trends of incidence and survival. Furthermore, this study may help better design healthcare policies and clinical management programs to balance the disparities of survival between SES groups, races, ages and sexes confirmed in this study and thereby improve the clinical management of HCC. Impact Journals LLC 2016-07-29 /pmc/articles/PMC5312351/ /pubmed/27486977 http://dx.doi.org/10.18632/oncotarget.10930 Text en Copyright: © 2016 Wang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Wang, Shuncong Sun, Huanhuan Xie, Zhinan Li, Jie Hong, Guobin Li, Dan Mallampati, Saradhi Zhou, Xiuling Zhou, Cuiling Zhang, Hongyu Cheng, Zhibin Shan, Hong Ma, Haiqing Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title_full | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title_fullStr | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title_full_unstemmed | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title_short | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
title_sort | improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312351/ https://www.ncbi.nlm.nih.gov/pubmed/27486977 http://dx.doi.org/10.18632/oncotarget.10930 |
work_keys_str_mv | AT wangshuncong improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT sunhuanhuan improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT xiezhinan improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT lijie improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT hongguobin improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT lidan improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT mallampatisaradhi improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT zhouxiuling improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT zhoucuiling improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT zhanghongyu improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT chengzhibin improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT shanhong improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 AT mahaiqing improvedsurvivalofpatientswithhepatocellularcarcinomaanddisparitiesbyageraceandsocioeconomicstatusbydecade19832012 |